Drug Shortage Report for VALSARTAN-HCTZ
Report ID | 104493 |
Drug Identification Number | 02367785 |
Brand name | VALSARTAN-HCTZ |
Common or Proper name | VALSARTAN HCTZ |
Company Name | PRO DOC LIMITEE |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE VALSARTAN |
Strength(s) | 25MG 160MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30,100 |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2020-01-27 |
Estimated end date | Unknown |
Actual end date | 2020-02-06 |
Shortage status | Resolved |
Updated date | 2020-02-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2020-02-07 | English | Compare |
v4 | 2020-02-06 | French | Compare |
v3 | 2020-02-06 | English | Compare |
v2 | 2020-01-28 | French | Compare |
v1 | 2020-01-28 | English | Compare |
Showing 1 to 5 of 5